Review article: pancreatic renin-angiotensin systems in health and disease
Open Access
- 19 August 2011
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 34 (8) , 840-852
Abstract
Aliment Pharmacol Ther 2011; 34: 840–852 Summary Background In addition to the circulating (endocrine) renin–angiotensin system (RAS), local renin–angiotensin systems are now known to exist in diverse cells and tissues. Amongst these, pancreatic renin–angiotensin systems have recently been identified and may play roles in the physiological regulation of pancreatic function, as well as being implicated in the pathogenesis of pancreatic diseases including diabetes, pancreatitis and pancreatic cancer. Aim To review and summarise current knowledge of pancreatic renin–angiotensin systems. Methods We performed an extensive PubMed, Medline and online review of all relevant literature. Results Pancreatic RAS appear to play various roles in the regulation of pancreatic physiology and pathophysiology. Ang II may play a role in the development of pancreatic ductal adenocarcinoma, via stimulation of angiogenesis and prevention of chemotherapy toxicity, as well as in the initiation and propagation of acute pancreatitis (AP); whereas, RAS antagonism is capable of preventing new‐onset diabetes and improving glycaemic control in diabetic patients. Current evidence for the roles of pancreatic RAS is largely based upon cell and animal models, whilst definitive evidence from human studies remains lacking. Conclusions The therapeutic potential for RAS antagonism, using cheap and widely available agents, and may be untapped and such roles are worthy of active investigation in diverse pancreatic disease states.Keywords
This publication has 146 references indexed in Scilit:
- Calmodulin protects against alcohol-induced pancreatic trypsinogen activation elicited via Ca 2+ release through IP 3 receptorsProceedings of the National Academy of Sciences, 2011
- Angiotensin-converting enzyme gene DD genotype neither increases susceptibility to acute pancreatitis nor influences disease severityHPB, 2009
- Angiotensin‐converting enzyme 2 in the brain: properties and future directionsJournal of Neurochemistry, 2008
- Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expressionBritish Journal of Pharmacology, 2008
- Involvement of an enterocyte renin–angiotensin system in the local control of SGLT1‐dependent glucose uptake across the rat small intestinal brush border membraneThe Journal of Physiology, 2007
- Pancreatic islet blood flow is selectively enhanced by captopril, irbesartan and pravastatin, and suppressed by palmitateBiochemical and Biophysical Research Communications, 2006
- Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on β-cell function and morphology in db/db miceBiochemical and Biophysical Research Communications, 2006
- Angiotensin II promotes the proliferation of activated pancreatic stellate cells by Smad7 induction through a protein kinase C pathwayBiochemical and Biophysical Research Communications, 2006
- Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonistBiochemical and Biophysical Research Communications, 2005
- Neointima formation after vascular injury is angiotensin II mediatedBiochemical and Biophysical Research Communications, 1992